244 results on '"Angiogenesis inhibitors -- Research"'
Search Results
2. National and Kapodistrian University of Athens Researchers Advance Knowledge in Neuroendocrine Cancer [Efficacy and Safety of First-Line Everolimus Therapy Alone or in Combination with Octreotide in Gastroenteropancreatic Neuroendocrine Tumors. ...]
3. New Antineoplastics Study Results Reported from Virgen de las Nieves University Hospital (Impact of Everolimus-based Immunosuppression on Renal Function in Liver Transplant Recipients)
4. Findings from Inje University Update Understanding of Tyrosine Kinase Inhibitors (Development of Self-microemulsifying Drug Delivery Systems of Poorly Water-soluble Pazopanib for Improvement of Oral Absorption)
5. Researchers at University Hospital of Canarias Target Tyrosine Kinase Inhibitors (Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial)
6. Report Summarizes Gastrointestinal Stromal Tumors Study Findings from Kunming Medical University (Preoperative therapy with sunitinib malate in a patient with a gastrointestinal stromal tumor and liver metastases)
7. New Migraine Findings from Department of Anesthesia Described (Celecoxib reduces cortical spreading depression-induced macrophage activation and dilatation of dural but not pial arteries in rodents: implications for mechanism of action in ...)
8. Findings from University of Alexandria Broaden Understanding of Lung Cancer (Inhalable Dual-targeted Hybrid Lipid Nanocore-protein Shell Composites for Combined Delivery of Genistein and All-trans Retinoic Acid To Lung Cancer Cells)
9. Findings from Pennsylvania State University (Penn State) Update Understanding of Genistein Therapy (Gender Differences in Phytoestrogens and the Relationship with Speed of Processing in Older Adults: A Cross-Sectional Analysis of NHANES, ...)
10. New Findings from Aix-Marseille University Yields New Data on Meningeal Neoplasms (Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial)
11. Findings in the Area of Acute Myeloid Leukemia Reported from Michigan Medicine [Lenalidomide Plus Hypomethylating Agent as a Treatment Option in Acute Myeloid Leukemia With Recurrent Genetic Abnormalities-AML With inv(3)(q21.3q26.2) or ...]
12. Studies from University for Health Sciences Further Understanding of Tyrosine Kinase Inhibitors (Efficacy of Pazopanib In Patients With Metastatic Uterine Sarcoma: a Multi-institutional Study)
13. Findings from Radiology Department Has Provided New Data on Lymphedema (Noncontrast Magnetic Resonance Lymphangiography in a Rare Case of Everolimus-Related Lymphedema)
14. Recent Studies from University of Athens Add New Data to Nanostructures (Marcromolecular Architecture and Encapsulation of the Anticancer Drug Everolimus Control the Self-assembly of Amphiphilic Polypeptide-containing Hybrids)
15. Reports Summarize Genistein Therapy Research from Faculty of Pharmaceutical Sciences (Antimutagenic components in Spatholobus suberectus Dunn against N-methyl-N-nitrosourea)
16. New POEMS Syndrome Findings from Akita University Reported (Multiparameter Flow Cytometry for the Identification of Neoplastic Plasma Cells in POEMS Syndrome with IgG-kappa Gammopathy: Successful Treatment Using Lenalidomide and Dexamethasone)
17. Researchers at Department of Orthopedics Target Heterotopic Ossification (Celecoxib cannot inhibit the progression of initiated traumatic heterotopic ossification)
18. Studies from University of Athens Update Current Data on Nanostructures (Marcromolecular Architecture and Encapsulation of the Anticancer Drug Everolimus Control the Self-Assembly of Amphiphilic Polypeptide-Containing Hybrids)
19. Studies from City of Hope National Medical Center Provide New Data on Breast Cancer (Phase I Clinical Trial of the Combination of Eribulin and Everolimus In Patients With Metastatic Triple-negative Breast Cancer)
20. Findings on Nanoparticles Reported by Researchers at Shenyang Pharmaceutical University (Continuous Production of Celecoxib Nanoparticles Using a Three-Dimensional-Coaxial-Flow Microfluidic Platform)
21. Researchers at Harvard University Report Findings in Central Nervous System Agents [Discovery of a Celecoxib Binding Site on Prostaglandin E Synthase (PTGES) with a Cleavable Chelation-Assisted Biotin Probe]
22. Recent Findings from University of the Witwatersrand Provides New Insights into Squamous Cell Carcinoma (Folate-decorated, Endostatin-loaded, Nanoparticles for Anti-proliferative Chemotherapy In Esophaegeal Squamous Cell Carcinoma)
23. Research from University of Hyderabad Yields New Findings on Staphylococcus aureus (Celecoxib potentiates antibiotic uptake by altering membrane potential and permeability in Staphylococcus aureus)
24. Recent Findings in Genistein Therapy Described by Researchers from Pennsylvania State University (Gender Differences in Phytoestrogens and the Relationship with Speed of Processing in Older Adults: A Cross-Sectional Analysis of NHANES, 1999-2002)
25. Findings from University of South Australia Provides New Data on Antineoplastics (Development of a physiologically based pharmacokinetic model for intravenous lenalidomide in mice)
26. Findings from University of Illinois in the Area of Solid Cancer Described [Phase I Study of Aurora a Kinase Inhibitor Alisertib (Mln8237) In Combination With Selective Vegfr Inhibitor Pazopanib for Therapy of Advanced Solid Tumors]
27. Studies Conducted by N.K. Dubey et al on Central Nervous System Agents Recently Reported (Overcoming the Charged Ion Competition in Triple Quad Chemical Ionization Ion Source for Estimation of Celecoxib in Biological Matrix and its Application ...)
28. Researchers at Radboud University Medical Center Target Tyrosine Kinase Inhibitors [The Effect of Using Pazopanib With Food vs. Fasted on Pharmacokinetics, Patient Safety, and Preference (DIET Study)]
29. Reports Outline Soft Tissue Sarcomas Study Results from Ohio State University (Effect of Acid-Suppressive Strategies on Pazopanib Efficacy in Patients With Soft-Tissue Sarcoma)
30. Findings from University of Chicago Update Understanding of Antineoplastics (Prolonged Pharmacokinetic Interaction Between Capecitabine and a CYP2C9 Substrate, Celecoxib)
31. Study Results from Auburn University in the Area of Pharmaceutical Research Reported (Microemulsion and Microporation Effects On the Genistein Permeation Across Dermatomed Human Skin)
32. Findings from Nanjing University of Traditional Chinese Medicine Broaden Understanding of Genistein Therapy [Solutol ® Hs15+pluronicf127 and Solutol ® Hs15+pluronicl61 Mixed Micelle Systems for Oral Delivery of Genistein]
33. New Findings on Liver Transpls Described by Investigators at Georg-August-University (Pantoprazole Does Not Affect Serum Trough Levels of Tacrolimus and Everolimus In Liver Transplant Recipients)
34. Reports Summarize Genistein Therapy Findings from University of Gdansk (Genistein induces degradation of mutant huntingtin in fibroblasts from Huntington's disease patients)
35. Investigators at University of Alexandria Describe Findings in Hypertension (Upregulation of Cystathionine-gamma-lyase/hydrogen Sulfide Pathway Underlies the Celecoxib Counteraction of Cyclosporine-induced Hypertension and Renal Insult In Rats)
36. Study Findings from F. Edward Hebert School of Medicine Provide New Insights into Genistein Therapy (Pharmacokinetic and Metabolomic Studies With Bio 300, a Nanosuspension of Genistein, In a Nonhuman Primate Model)
37. Recent Findings from Aarhus University Hospital Provides New Insights into Antineoplastics (Everolimus-eluting Versus Biolimus-eluting Stents With Biodegradable Polymers In Unselected Patients Undergoing Percutaneous Coronary Intervention)
38. Findings in the Area of Diabetes Mellitus Reported from Jichi Medical University Hospital (Conversion From Steroid To Everolimus In Maintenance Kidney Transplant Recipients With Posttransplant Diabetes Mellitus)
39. Studies from University of Tokyo Hospital in the Area of Soft Tissue Sarcomas Reported (Neutrophil-to-lymphocyte Ratio After Pazopanib Treatment Predicts Response In Patients With Advanced Soft-tissue Sarcoma)
40. Findings from Fudan University Provides New Data about Pancreatic Cancer (Angiogenesis In Pancreatic Cancer: Current Research Status and Clinical Implications)
41. Researchers from Shandong University Detail New Studies and Findings in the Area of Thyroid Cancer (Genistein inhibits human papillary thyroid cancer cell detachment, invasion and metastasis)
42. New Findings from U. Cillo and Colleagues Has Provided New Data on Antineoplastics (Very Early Introduction of Everolimus in De Novo Liver Transplantation: Results of a Multicenter, Prospective, Randomized Trial)
43. New Colon Cancer Study Results from Sungkyunkwan University School of Medicine Described (A Single Arm, Phase II Study of Simvastatin Plus XELOX and Bevacizumab as First-Line Chemotherapy in Metastatic Colorectal Cancer Patients)
44. Investigators from Cleveland Clinic Zero in on Prostate Cancer [Ketoconazole plus Lenalidomide in patients with Castration-Resistant Prostate Cancer (CRPC): results of an open-label phase II study]
45. Findings from General Hospital Provides New Data about Antineoplastic Monoclonal Antibodies (Chemotherapy Plus Bevacizumab as Neoadjuvant or Conversion Treatment in Patients with Colorectal Liver Metastases)
46. Studies from University of Athens Yield New Information about Multiple Myeloma (Elotuzumab Plus Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Extended 4-Year Follow-Up and Analysis of Relative Progression-Free Survival ...)
47. New Findings on Restenosis from Department of Cardiovascular Medicine Summarized (In-Stent Restenosis with 'Inflammatory' Neointima Following Everolimus-Eluting Stent Implantation In Vivo Optical Coherence Tomography and Histopathological ...)
48. New Findings Reported from Maastricht University Describe Advances in Kidney Cancer (Tyrosine Kinase Inhibitor Pazopanib Inhibits Platelet Procoagulant Activity in Renal Cell Carcinoma Patients)
49. Study Results from University Hospital of Asturias in the Area of Heart Transplants Reported (Early Everolimus Initiation Fails to Counteract the Cytotoxic Response Mediated by CD8+ T and NK Cells in Heart Transplant Patients)
50. Studies from Beth Israel Deaconess Medical Center Yield New Information about Kidney Cancer (Comprehensive Genomic Profiling of Metastatic Tumors in a Phase 2 Biomarker Study of Everolimus in Advanced Renal Cell Carcinoma)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.